NCT00815386 - Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2015

Conditions

Mitral RegurgitationHeart Failure

Interventions

DEVICE

Percutaneous transvenous mitral annuloplasty

Catheterization procedure with anesthesia requiring subclavicular puncture, catheterization of the right atrium and coronary sinus vein, placement and optimization of the PTMA device with access hub remaining subcutaneous at the clavicle.

Trial Locations (3)

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

H3A1A1

Royal Victoria Hospital, McGill University Medical Center, Montreal

G1V4G5

Laval Hospital, Quebec Heart-Lung Institute, Québec